Samus Therapeutics
0 followers
Samus Therapeutics is a privately held Boston-based biopharmaceutical company developing novel therapeutics targeting the epichaperome, a foundational protein complex emergent from multiple disease states, including cancer and neurological disorders such as Alzheimer’s, Parkinson’s, and chronic trau... Read more
Org chart
Richard Bagley
President & CEO
Richard Bagley
Collapse
Michael H. Silverman
Acting Chief Medical Officer
Barbara Wallner
Chief Scientific Officer
Marc Swikalus
VP, Finance & Controller
John Amedio
Acting Head of Manufacturing
Sharlene Cirillo
Head, Commercial Strategy & Business Development
Gregory Hileman
Head, Regulatory Affairs
Robert Morgan
Head, Development Operations
Stacey Channing
Patent Counsel
